SCHEMBL6789281

SCHEMBL6789281

COc1ccc(-c2ccccc2C(=O)Nc2ccc(CCc3cccc(N)n3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.59
POLB P06746 2/20 0.59
ABCG2 Q9UNQ0 2/20 0.48
KDM4E B2RXH2 4/20 0.48
NR1H4 Q96RI1 1/20 0.47
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
MAPT P10636 2/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
BACE1 P56817 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 2/20 0.46
NPSR1 Q6W5P4 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CYP3A4 P08684 1/20 0.45
BRS3 P32247 1/20 0.44
METAP2 P50579 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6788782 0.90 GAA (0.59) GAAPOLBKDM4EMEN1KMT2A
SCHEMBL6793400 0.88 POLB (0.58) GAAPOLBABCG2KDM4ENR1H4
SCHEMBL6799624 0.85 PTGS1 (0.50) ALDH1A1SMN1; SMN2
SCHEMBL6793279 0.82 POLB (0.47) GAAPOLBMEN1KMT2AMAPT
SCHEMBL6792277 0.82 NPC1 (0.46) GAAPOLBNR1H4MEN1KMT2A
Hydrochloric Acid SCHEMBL6792674 0.81 POLB (0.47) GAAPOLBMEN1KMT2AMAPT
SCHEMBL6792554 0.79 PTGS1 (0.48) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL6800432 0.79 L3MBTL1 (0.46) GAAPOLBKMT2AALDH1A1LMNA
SCHEMBL6798535 0.78 ATR (0.44) GAAPOLBMAPTALDH1A1SMN1; SMN2
SCHEMBL6800986 0.78 GAA (0.64) GAAPOLBKDM4ENR1H4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 GAA 977/4885POLB 1470/4885ABCG2 501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.